Cardiovascular disease-associated admissions in patients with Cystic Fibrosis: A 7-Year U.S. National Inpatient Sample Analysis
Heart Lung. 2026 Jan 8;78:102701. doi: 10.1016/j.hrtlng.2025.102701. Online ahead of print.ABSTRACTBACKGROUND: As survival improves for people with cystic fibrosis (PwCF) in the era of CFTR modulators, cardiovascular (CV) diseases are emerging as clinically important comorbidities. Beyond age-relate

